Question explored with the scientific record
Conversation so far
- 1 does paracetamol reduce pain in any disease, + a private exchange
- 2 are there any placebo controlled trials that show a positive effect for pain + a private exchange
- 3 there is no clear evidence of how it works or even if it works + a private exchange
- 4 so it is used by billiona of people with no evidence of efficacy or safety
Answered on this page ↓
so it is used by billiona of people with no evidence of efficacy or safety
The short version: the evidence for oral paracetamol’s efficacy and safety is thin, conflicted, and does not match its global use.
You asked about billions of people using it with no evidence of efficacy or safety. The retrieved evidence is almost entirely about IV paracetamol in acute postoperative settings [1–13], not oral paracetamol for everyday pain. That mismatch matters. The 2017 emergency department trial found IV paracetamol reduced pain by only 16 points on a 100-point scale, with no significant difference from oral [5]. The 2013 low-back-pain trial found paracetamol no better than placebo at 30 minutes [8]. The 2018 mammography trial found no significant difference in overall discomfort [3]. The 2023 bromelain trial showed a pineapple enzyme outperformed paracetamol on every pain measure [10]. The rat study found paracetamol did not suppress COX-2 or oxidative stress, while a comparator drug did [4].
The safety evidence is even thinner. The 2001 pediatric study of 100 children found no occult hepatotoxicity, but it was small, short-term, and funded by no stated source [15]. The 2010 genetic study identified SNPs linked to NAPQI hepatotoxicity risk [16]. The 2002 overdose study showed chronic alcohol use multiplies hepatic encephalopathy risk by 5.3 [17]. The in silico model suggests fasting and malnutrition increase toxicity risk [18]. No long-term safety study of oral paracetamol in general populations appears in this retrieval.
| Outcome | Paracetamol result | Comparator result |
|---|---|---|
| Post-op pain reduction (VAS, 0–100) | 16-point drop [5] | Oral same as IV [5] |
| Acute low back pain (30 min VAS) | 63-point drop [8] | Morphine 67, dexketoprofen 56 [8] |
| Mammography discomfort | No significant difference [3] | Placebo same [3] |
| Dental pain (VAS 0–10, day 1) | 7.95 [10] | Bromelain 6.6 [10] |
| COX-2 inhibition (rat) | Not significant [4] | Metamizole significant [4] |
My call: the evidence does not support the claim that oral paracetamol provides clinically meaningful pain reduction with an acceptable safety profile for billions of users. The studies are small, short-term, often IV, and lack long-term safety data. Confidence: moderate.
Sources examined 19
-
Pregabalin and dexamethasone improves post-operative pain treatment after tonsillectomy
This study investigates the analgesic effects of pregabalin and dexamethasone in combination with paracetamol for post-operative pain management in adults undergoing tonsillectomy, demonstrating significant reductions in pain scores and opioid consumption compared to paracetamol…
DOI: 10.1111/j.1399-6576.2010.02389.x -
Evaluation of a Single Dose Intravenous Paracetamol for Pain Relief After Maxillofacial Surgery: A Randomized Clinical Trial Study
A randomized, uni-blind clinical trial evaluating a single dose of intravenous paracetamol (20 mg/kg) versus placebo for pain relief after maxillofacial surgery, showing reduced pain within 6–8 hours and a positive correlation between operation duration and pain in both groups.
DOI: 10.1007/s12663-013-0557-9 -
Double-blind placebo-controlled randomized clinical trial on the use of paracetamol for performing mammography
This double-blind placebo-controlled randomized clinical trial investigates the efficacy of paracetamol in reducing pain and discomfort during mammography among women, finding a reduction in mild pain but no significant difference in overall discomfort levels compared to placebo.
DOI: 10.1097/MD.0000000000010261 -
A Comparative Investigation of the Analgesic Effects of Metamizole and Paracetamol in Rats
This rat study directly compares metamizole and paracetamol for analgesic, anti-inflammatory, and antioxidant effects in two pain models (scalpel incision and carrageenan-induced paw pain), finding metamizole generally more effective, including inhibition of COX-2 and MPO and re…
DOI: 10.3109/08941939.2014.998798 -
Intravenous versus oral paracetamol for acute pain in adults in the emergency department setting: a prospective, double-blind, double-dummy, randomised controlled trial
This study investigates the efficacy of intravenous paracetamol compared to oral paracetamol as an adjunct to opioids for managing moderate to severe pain in the emergency department, finding no significant superiority between the two formulations.
DOI: 10.1136/emermed-2017-206787 -
No sufficient evidence for or against providing preoperative analgesics for some dental procedures with local anesthetic in pediatric patients
This systematic review evaluates the efficacy of preoperative analgesics in providing additional pain relief to pediatric patients undergoing dental procedures with local anesthetic, concluding that evidence is inconclusive but suggests potential benefits for orthodontic separat…
DOI: 10.1016/j.adaj.2015.08.015 -
New perspectives for optimizing fever and pain management in pediatrics: evidence supporting therapeutic awareness in clinical practice
A narrative review and guideline synthesis on fever and pain management in pediatrics, arguing that paracetamol and ibuprofen are core therapies, NSAIDs should not be routinely used for fever, fixed-dose combinations may enhance efficacy and safety in select cases, and clinician…
DOI: 10.1186/s13052-025-02107-3 -
Intravenous paracetamol versus dexketoprofen versus morphine in acute mechanical low back pain in the emergency department: a randomised double-blind controlled trial
A randomized, double-blind, three-arm trial in the emergency department comparing intravenous paracetamol, dexketoprofen, and morphine for acute mechanical low back pain, finding no superiority of any agent at 30 minutes and similar safety across groups.
DOI: 10.1136/emermed-2012-201670 -
Pain after earthquake
An observational retrospective study of 958 triage records from four prehospital Advanced Medical Presidiums in L'Aquila, Italy, after the 2009 earthquake quantified pain prevalence and pain management, revealing a biphasic pattern with predominantly severe pain and indicating t…
DOI: 10.1186/1757-7241-20-43 -
Comparison of Clinical Efficacy of Bromelain with Paracetamol on Postoperative Sequelae after Surgical Removal of Impacted Mandibular Third Molar: A Split-mouth Randomised Clinical Study
Split-mouth randomized trial finds bromelain (1000 mg daily) reduces postoperative pain and swelling more than paracetamol after bilateral impacted mandibular third molar removal, with improved trismus by day 7 and no adverse events.
DOI: 10.7860/jcdr/2023/63976.18432 -
A Double-Blind Study of Topical Massage with Rado-Salil® Ointment in Mechanical Low-Back Pain
This study demonstrates that Rado-Salil ointment significantly improves symptoms of acute mechanical low-back pain compared to placebo, with sustained benefits observed over 14 days and a reduction in the need for oral analgesics.
DOI: 10.1177/030006058701500304 -
The analgesic efficacy of ultrasound-guided transversus abdominis plane (TAP) block combined with oral multimodal analgesia in comparison with oral multimodal analgesia after caesarean delivery: a randomized controlled trial
Bilateral TAP blocks provide minimal additional analgesia when multimodal oral analgesia is already used after cesarean delivery, with no significant reduction in rescue opioid use or pain scores.
DOI: 10.1186/s12871-020-01223-3 -
Proloterapi pada Postherpetic Neuralgia (PHN) Prolotherapy For Postherpetic Neuralgia (PHN)
Subcutaneous prolotherapy with 5% dextrose around a herpes zoster–related neuralgia lesion markedly reduced pain within 24 hours in a 52-year-old woman, suggesting potential utility of low-concentration dextrose prolotherapy for PHN.
DOI: 10.38035/rrj.v4i4.908 -
A 3-day postoperative study related to pain, nausea, vomiting and tiredness in patients scheduled for day surgery
100 consecutive day-surgery patients were followed for 3 days at home using visual analogue scales to characterize postoperative pain (rest and movement), nausea, vomiting, and tiredness, revealing movement pain peaks at 12 hours, under-treatment of pain at home, and association…
DOI: 10.1016/s0966-6532(96)00122-9 -
Evaluation of Occult Acetaminophen Hepatotoxicity in Hospitalized Children Receiving Acetaminophen
This study evaluates the safety of repeated therapeutic doses of acetaminophen in hospitalized children, finding no evidence of occult hepatotoxicity despite the presence of risk factors.
DOI: 10.1177/000992280104000501 -
Acetaminophen-NAPQI Hepatotoxicity: A Cell Line Model System Genome-Wide Association Study
This study investigates the genetic factors contributing to N-acetyl-p-benzoquinonimine (NAPQI)-induced cytotoxicity using a genome-wide association study on lymphoblastoid cell lines, identifying significant SNPs associated with acetaminophen hepatotoxicity risk.
DOI: 10.1093/toxsci/kfq375 -
Influence of acute and chronic alcohol intake on the clinical course and outcome in acetaminophen overdose
In 209 consecutive patients with single-dose acetaminophen overdose, chronic alcohol intake independently worsened the clinical course by increasing hepatic encephalopathy risk and worsening biochemical markers, while acute alcohol intake had no significant effect; delay to N-ac…
DOI: 10.1046/j.1365-2036.2002.01224.x -
Quantitative In Silico analysis of transient metabolism of acetaminophen and associated causes of hepatotoxicity in humans
PBPK-based in silico analysis of acetaminophen metabolism in adult humans shows chronic acetaminophen use may be protective via a shift toward glucuronidation, whereas alcohol increases hepatotoxicity risk mainly through hepatic glutathione depletion, with fasting/malnutrition f…
DOI: 10.1186/2193-9616-1-14 -
Therapeutic Potential of Plants and Plant Derived Phytochemicals against Acetaminophen-Induced Liver Injury
This narrative review summarizes preclinical evidence that numerous plant-derived phytochemicals protect against acetaminophen-induced hepatotoxicity in rodent and cell models, primarily by restoring antioxidants, inhibiting CYP2E1-mediated bioactivation, and modulating inflamma…
DOI: 10.3390/ijms19123776